ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1023

Does Clinical Utility of the Kidney Failure Risk Equation in Routine Clinical Practice Vary by Socioeconomic Status?

Session Information

Category: Diversity and Equity in Kidney Health

  • 900 Diversity and Equity in Kidney Health

Authors

  • Walker, Heather, University of Glasgow College of Medical Veterinary and Life Sciences, Glasgow, Glasgow, United Kingdom
  • Khan, Shabana, University of Glasgow College of Medical Veterinary and Life Sciences, Glasgow, Glasgow, United Kingdom
  • Jani, Bhautesh Dinesh, University of Glasgow College of Medical Veterinary and Life Sciences, Glasgow, Glasgow, United Kingdom
  • Gallacher, Katie I., University of Glasgow College of Medical Veterinary and Life Sciences, Glasgow, Glasgow, United Kingdom
  • Mark, Patrick Barry, University of Glasgow College of Medical Veterinary and Life Sciences, Glasgow, United Kingdom
  • Sullivan, Michael K., University of Glasgow College of Medical Veterinary and Life Sciences, Glasgow, United Kingdom
Background

Risk prediction models such as the kidney failure risk equation (KFRE) have been recommended to identify patients at heightened risk of kidney failure requiring treatment (KFRT). Incorporating KFRE into clinical practice may be limited by rates of albuminuria testing. We used routine healthcare data to ascertain albuminuria testing rates in CKD by sub-groups including socio-economic deprivation, age or sex.

Methods

We used routine healthcare data for all adults in NHS Greater Glasgow, UK (population approximately 1.5mill). Two cohorts and analyses were performed. Analysis 1 cohort: CKD G3-5 (eGFR<60mL/min/1.73m2 for >90 days without KFRT). Analysis 2 cohort: as per cohort 1 with albuminuria values within 6 months of meeting CKD diagnostic criteria. Analysis 1 used logistic regression models to quantify associations between predictor variables and albuminuria testing. Analysis 2 assessed the predictive performance of KFRE.

Results

Cohort 1 included 10,874 adults. Albuminuria testing was missing in 55.5% of people. Individuals most likely to have albuminuria testing were those aged 40-50 years (adjusted odds ratio (aOR) 1.83 (95% confidence interval (CI) 1.15-2.91), p=0.01) and those living in the least socioeconomically deprived areas (aOR 1.11 (95% CI 1.00-1.23), p=0.01). Individuals least likely to have albuminuria testing were females (aOR 0.86 (95% CI 0.79-0.93), p<0.001), those with hypertension (aOR 0.69 (95% CI 0.63-0.77), p<0.001) and those without a diagnosis of diabetes (aOR 0.43 (95% CI 0.39-0.47), p<0.001).
Cohort 2 included 4,902 adults, median eGFR 51.5 ml/min/1.73m2. The highest albuminuria and KFRE risk values were identified in males, those aged 40-50 years old, people with a diagnosis of diabetes and individuals living in the most socio-economically deprived areas. KFRE model performance at five years was good but with over prediction at higher KFRE predicted risk groups (AUC 0.82).

Conclusion

KFRE performed well in this large observational population-based study using routinely collected data. KFRE could only be calculated for less than half of adults with CKD due to low rates of albuminuria testing, particularly for females, those without diabetes and those living in the most deprived areas.

Funding

  • Private Foundation Support